Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML) Meeting Abstract

  


Authors: Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
Abstract Title: Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
Meeting Title: 49th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 110
Issue: 11 Pt. 1
Meeting Dates: 2007 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2007-11-01
Start Page: 277A
Language: English
ACCESSION: WOS:000251100801179
PROVIDER: wos
PUBMED: 18092369
DOI: 10.1182/blood.V110.11.910.910
Notes: --- - Meeting Abstract: 910 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 1 - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael R Mcdevitt
    144 Mcdevitt
  2. Mark Frattini
    45 Frattini
  3. Neeta Pandit-Taskar
    342 Pandit-Taskar
  4. Suzanne M Chanel
    31 Chanel
  5. David Scheinberg
    499 Scheinberg
  6. Jorge Carrasquillo
    140 Carrasquillo
  7. Todd Louis Rosenblat
    21 Rosenblat
  8. Steven M Larson
    958 Larson
Related MSK Work